Your browser doesn't support javascript.
loading
The protective gene dose effect of the APOE ε2 allele on gray matter volume in cognitively unimpaired individuals.
Salvadó, Gemma; Ferreira, Daniel; Operto, Grégory; Cumplido-Mayoral, Irene; Arenaza-Urquijo, Eider M; Cacciaglia, Raffaele; Falcon, Carles; Vilor-Tejedor, Natàlia; Minguillon, Carolina; Groot, Colin; van der Flier, Wiesje M; Barkhof, Frederik; Scheltens, Philip; Ossenkoppele, Rik; Kern, Silke; Zettergren, Anna; Skoog, Ingmar; Hort, Jakub; Stomrud, Erik; van Westen, Danielle; Hansson, Oskar; Molinuevo, José Luis; Wahlund, Lars-Olof; Westman, Eric; Gispert, Juan Domingo.
Afiliación
  • Salvadó G; Barcelonaßeta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Spain.
  • Ferreira D; IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
  • Operto G; Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.
  • Cumplido-Mayoral I; Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA.
  • Arenaza-Urquijo EM; Barcelonaßeta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Spain.
  • Cacciaglia R; IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
  • Falcon C; CIBER Fragilidad y Envejecimiento Saludable (CIBERFES), Madrid, Spain.
  • Vilor-Tejedor N; Barcelonaßeta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Spain.
  • Minguillon C; Universitat Pompeu Fabra, Barcelona, Spain.
  • Groot C; Barcelonaßeta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Spain.
  • van der Flier WM; IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
  • Barkhof F; CIBER Fragilidad y Envejecimiento Saludable (CIBERFES), Madrid, Spain.
  • Scheltens P; Barcelonaßeta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Spain.
  • Ossenkoppele R; IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
  • Kern S; CIBER Fragilidad y Envejecimiento Saludable (CIBERFES), Madrid, Spain.
  • Zettergren A; Barcelonaßeta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Spain.
  • Skoog I; IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
  • Hort J; Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Madrid, Spain.
  • Stomrud E; Barcelonaßeta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Spain.
  • van Westen D; Universitat Pompeu Fabra, Barcelona, Spain.
  • Hansson O; Centre for Genomic Regulation (CRG), The Barcelona Institute for Science and Technology, Barcelona, Spain.
  • Molinuevo JL; Department of Clinical Genetics, ERASMUS MC, Rotterdam, the Netherlands.
  • Wahlund LO; Barcelonaßeta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Spain.
  • Westman E; IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
  • Gispert JD; CIBER Fragilidad y Envejecimiento Saludable (CIBERFES), Madrid, Spain.
Alzheimers Dement ; 18(7): 1383-1395, 2022 07.
Article en En | MEDLINE | ID: mdl-34877786
ABSTRACT

INTRODUCTION:

Harboring two copies of the apolipoprotein E (APOE) ε2 allele strongly protects against Alzheimer's disease (AD). However, the effect of this genotype on gray matter (GM) volume in cognitively unimpaired individuals has not yet been described.

METHODS:

Multicenter brain magnetic resonance images (MRIs) from cognitively unimpaired ε2 homozygotes were matched (11) against all other APOE genotypes for relevant confounders (n = 223). GM volumes of ε2 genotypic groups were compared to each other and to the reference group (APOE ε3/ε3).

RESULTS:

Carrying at least one ε2 allele was associated with larger GM volumes in brain areas typically affected by AD and also in areas associated with cognitive resilience. APOE ε2 homozygotes, but not APOE ε2 heterozygotes, showed larger GM volumes in areas related to successful aging.

DISCUSSION:

In addition to the known resistance against amyloid-ß deposition, the larger GM volumes in key brain regions may confer APOE ε2 homozygotes additional protection against AD-related cognitive decline.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Dosificación de Gen / Apolipoproteína E2 / Enfermedad de Alzheimer / Disfunción Cognitiva Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Alzheimers Dement Año: 2022 Tipo del documento: Article País de afiliación: España

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Dosificación de Gen / Apolipoproteína E2 / Enfermedad de Alzheimer / Disfunción Cognitiva Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Alzheimers Dement Año: 2022 Tipo del documento: Article País de afiliación: España